HomeVX1 • FRA
add
Vertex Pharmaceuticals Inc
Nakaraang pagsara
€424.75
Sakop ng araw
€411.20 - €424.20
Sakop ng taon
€357.00 - €487.00
Market cap
122.24B USD
Average na Volume
81.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Sa balita
The Motley Fool
4 oras ang nakalipas
Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals?
0.00%
1.81%
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 2.91B | 15.66% |
Gastos sa pagpapatakbo | 345.00M | -6.53% |
Net na kita | 913.00M | -5.76% |
Net profit margin | 31.35 | -18.53% |
Kita sa bawat share | 3.98 | -5.24% |
EBITDA | 1.33B | 32.70% |
Aktuwal na % ng binabayarang buwis | 19.67% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 6.12B | -45.48% |
Kabuuang asset | 22.53B | -0.87% |
Kabuuang sagutin | 6.12B | 18.91% |
Kabuuang equity | 16.41B | — |
Natitirang share | 256.79M | — |
Presyo para makapag-book | 6.65 | — |
Return on assets | 14.63% | — |
Return on capital | 18.42% | — |
Cash Flow
Net change in cash
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 913.00M | -5.76% |
Cash mula sa mga operasyon | 584.60M | 149.19% |
Cash mula sa pag-invest | -821.90M | 7.29% |
Cash mula sa financing | -391.30M | -226.63% |
Net change in cash | -675.90M | 9.19% |
Malayang cash flow | 110.54M | -75.35% |
Tungkol
Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. It maintains headquarters in Boston, Massachusetts, and three research facilities, in San Diego, California, and Milton Park, Oxfordshire, England. Wikipedia
Itinatag
1989
Headquarters
Website
Mga Empleyado
6,100
